Osteomyelitis

From IDWiki
Revision as of 09:01, 14 January 2021 by Aidan (talk | contribs)

Management

  • No clinically meaningful differences in bone penetration between classes of antibiotics exist1
  • Bioavailability likely still important
  • Empiric antimicrobials should generally cover MRSA, susceptible Gram-positives, and common Gram-negatives

Parenteral Antimicrobials

Organism Antimicrobial Options

Oral Antimicrobials

Organism Antibiotic Options
MSSA cefadroxil 500 to 1000 mg PO bid
cephalexin 500 mg PO tid to qid, or 1000 mg PO bid to tid
dicloxacillin 500 mg PO tid to qid
flucloxaxillin 500 mg PO tid to qid
MRSA TMP-SMX DS 1 tablet PO bid
doxycycline 100 mg PO bid
minocycline 100 mg PO bid
clindamycin 600 mg PO tid
Gram-negative bacteria TMP-SMX DS 1 tablet PO bid
ciprofloxacin 500 mg PO bid
levofloxacin 500 mg PO daily
penicillin-susceptible streptococci and enterococci amoxicillin 500 mg PO bid to tid
penicillin VK 500 mg PO bid to tid
Cutibacterium acnes amoxicillin 500 mg PO bid to tid
penicillin VK 500 mg PO bid to tid

References

  1. ^  Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.